Dark biotechnology, often referred to as "black biotechnology," encompasses the application of biotechnological processes to develop products or technologies with potentially harmful or controversial implications. Unlike its counterparts in white and red biotechnology, which focus on medical and industrial applications, dark biotechnology delves into areas that raise ethical concerns. This field includes activities such as bio-warfare research, bioterrorism, and the creation of biological weapons. The manipulation of living organisms for destructive purposes has sparked debates about the ethical boundaries and the need for stringent regulations to prevent the misuse of scientific advancements. The ethical considerations surrounding dark biotechnology highlight the importance of responsible research practices and global cooperation to mitigate the potential risks associated with these controversial applications.
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico